Pathogenic Lrrk2 substitutions and amyotrophic lateral sclerosis

A. J. Whittle, O. A. Ross, A. Naini, P. Gordon, H. Mistumoto, J. C. Dächsel, J. T. Stone, Z. K. Wszolek, M. J. Farrer, S. Przedborski

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Pathogenic Lrrk2 Y1699C substitution observed in a large German-Canadian kindred presents a neurodegenerative disorder that is reminiscent of amyotrophic lateral sclerosis and Parkinsonism-Dementia Complex. We screened 54 patients with ALS for seven known Lrrk2 pathogenic substitutions in the Roc, COR and kinase domains. No mutations were observed suggesting that this locus does not have a major influence on the ALS phenotype. However we can not rule out other genetic variation at the LRRK2 locus may play a role in parkinsonian disorders with amyotrophic lateral sclerosis and may be considered candidates for genetic screening.

Original languageEnglish (US)
Pages (from-to)327-329
Number of pages3
JournalJournal of Neural Transmission
Issue number3
StatePublished - Mar 2007


  • Amyotrophic lateral sclerosis
  • Lrrk2
  • Pathogenic substitutions

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry


Dive into the research topics of 'Pathogenic Lrrk2 substitutions and amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

Cite this